Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

C8 Science Panel Linking Of Testicular Cancer and C8 Tainted Water Draws Comment From Wright & Schulte LLC
  • USA - English


News provided by

Wright & Schulte LLC

Nov 06, 2013, 11:55 ET

Share this article

Share toX

Share this article

Share toX

If you believe you or a loved one have been exposed to C8 contaminated drinking water, contact Wright & Schulte LLC for a FREE C8 lawsuit case evaluation at www.yourlegalhelp.com or 1-800-399-0795.
If you believe you or a loved one have been exposed to C8 contaminated drinking water, contact Wright & Schulte LLC for a FREE C8 lawsuit case evaluation at www.yourlegalhelp.com or 1-800-399-0795.

For more information on DuPont C8 contaminated drinking water visit www.yourlegalhelp.com or call 1-800-399-0795 for a FREE C8 lawsuit case evaluation.

Post this

Columbus, OH (PRWEB) November 06, 2013 -- According to Wright & Schulte, a study completed by the C8 Science panel appears to confirm allegations contained in C8 lawsuits filed by victims of testicular cancer, and will likely be presented as evidence in those claims. (In Re: E.I. DuPont De Nemours and Company C-8 Personal Injury Litigation, MDL No. 2433) The C8 Science Panel has concluded that there is a probable link between exposure to C8 contaminated drinking water and certain types of cancer, including testicular cancer, Wright & Schulte LLC reports. According to the Firm, the finding paves the way for certain Mid-Ohio Valley residents who lived or worked in the vicinity of DuPont’s Washington Works Plant in Parkersburg, West Virginia prior to December 1, 2004, to file a C8 cancer lawsuit if they were diagnosed with testicular cancer. (In Re: E.I. DuPont De Nemours and Company C-8 Personal Injury Litigation, MDL No. 2433) [usatoday.com/story/money
/business/2013/10/26/9-us-residents-sue-dupont-
co-over-cancer/3252015/, October, 26 2013]
[c8sciencepanel.org/pdfs/Probable_Link_C8_Cancer_
16April2012_v2.pdf, C8 Science Panel, April 2012]

The C8 Panel was created under DuPont’s 2005 C8 class action lawsuit settlement, which affected more than 70,000 people who lived and worked near the DuPont facility. ((Leach v. E.I. Du Pont De Nemours & Co., No. 01-C-608 (W. Va. Cir. Ct.) According to court documents, the Panel was charged with investigating potential links between exposure to the chemical and a number of serious illnesses. The settlement also held that individuals who were exposed to C8 contaminated water associated with the Washington Works plant would be entitled to file an individual C8 lawsuit against DuPont if they developed any ailment deemed a probable linked disease by the C8 Panel. To do so, potential claimants must have lived or worked in one of six water districts included in the agreement prior to December 1, 2004:

• Little Hocking, Ohio
• Belpre, Ohio
• Village of Pomeroy, Ohio
• Tuppers Plains, Ohio
• Lubeck Public Service District, West Virginia
• Mason County Public Service District, West Virginia

In reaching its determination on testicular cancer, the C8 Science Panel looked at a number of studies, including one that involved 32,000 people who were interviewed between 2009 and 2011. Using records of past emissions from the DuPont plant and the residential history of study subjects, the Panel estimated the level of C8 in the blood of the subjects over time before cancer occurred. They found that as C8 levels increased, the rate of testicular cancer was 80 to 70 percent higher. A second C8 Science Panel study that looked at geographical areas with the highest C8 exposure corresponded to the highest rates of testicular cancer
[c8sciencepanel.org/pdfs/Probable_Link_C8_Cancer_16April2012_v2.pdf, C8 Science Panel, April 2012]

In addition to testicular cancer, the Panel concluded in October 2012 that there were probable links between exposure to C8 contaminated drinking water and several other serious ailments, including:

• Kidney Cancer
• Thyroid disease
• Inflammatory bowel disease (ulcerative colitis)
• Preeclampsia (high blood pressure during pregnancy)
• High cholesterol
[c8sciencepanel.org/prob_link.html; C8 Science Panel, October 2012]

According to court documents, individuals covered by the terms of the C8 class action lawsuit settlement who have developed illnesses that may be associated with pollution from the Washington Works facility have begun to file personal injury lawsuits against DuPont. In April 2013, a multidistrict litigation was established in U.S. District Court, Southern District of Ohio to consolidate those claims for pretrial proceedings. Richard W. Schulte, a partner with Wright & Schulte LLC, is a member of the Plaintiffs’ Steering Committee in the proceeding. Trials in the litigation are expected to begin in the fall of 2015. (In Re: E.I. DuPont De Nemours and Company C-8 Personal Injury Litigation, MDL No. 2433)

Wright & Schulte LLC has already filed numerous C8 lawsuits on behalf of Mid-Ohio Valley residents allegedly sickened by drinking water contaminated with C8. The Firm continues to offer free C8 lawsuit evaluations to anyone interested in filing an individual personal injury or wrongful death claim against DuPont. To learn more about C8 lawsuits, please call 1-888-399-0795, or visit http://www.yourlegalhelp.com.

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free DuPont C8 lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

For updated C8 lawsuit information like u s on our C8 Facebook page

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com

Richard Schulte, Wright & Schulte LLC, http://www.yourlegalhelp.com, +1 1-800-399-0795, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.